Research Article 
Agreement and reasons for disagreement between photographic and hospital biomicroscopy grading of diabetic retinopathy
A. Sallam, P. H. Scanlon, I. M. Stratton, V. Jones, C. N. Martin, M. Brelen and R. L. Johnston
Diabetic Medicine, 2011, 28(6), 741-746. DOI: 10.1111/j.1464-5491.2011.03273.x
Abstract
Aims To compare agreement level and identify reasons for disagreement between grading of mydriatic digital photographs in a diabetic retinopathy screening service and hospital eye service biomicroscopy grading.
Methods Structured examination findings leading to automatically calculated National Screening Committee grades recorded on an electronic medical record system in the hospital eye service at the first clinic visit after diabetic retinopathy screening service referral between April 2006 and November 2007 were retrospectively compared with the grade at the screening visit that prompted referral. In cases of disagreement, screening images were reviewed.
Results Data on 452 eyes (226 patients) were analysed. For retinopathy, hospital eye service slit-lamp biomicroscopy grades were: R0 (no diabetic retinopathy) in 63 eyes; R1 (background retinopathy) in 251eyes; R2 (pre-proliferative) in 129 eyes and R3 (proliferative) in nine eyes. Diabetic retinopathy screening service grades were in agreement in 350 eyes (77.4%), showed a lower grade in 59 eyes and a higher grade in 43. Agreement was moderate (κ = 0.60). The most common reason for disagreement was overgrading of R1 by clinicians. Hospital eye service biomicroscopy maculopathy grades were: M0 (no maculopathy) in 366 eyes and M1 (maculopathy) in 86 eyes. Diabetic retinopathy screening service grades were in agreement in 327 eyes (72.3%), showed a lower grading in five eyes and a higher grade in 120 eyes. Agreement was moderate (κ = 0.41). The commonest cause for disagreement was clinicians failing to identify fine macular exudates.
Conclusions This study of routine clinical services demonstrates moderate agreement between non-medical grading of mydriatic digital retinal photography images and hospital slit-lamp biomicroscopy grading of patients referred with diabetic retinopathy. The majority of errors in grading were attributable to errors by hospital doctors, usually in the direction of under-grading which could be a potential source of clinical risk if treatment is delayed.
ASCI-ID: 109-855
Similar Articles
Leptin-a predictor of abnormal glucose tolerance and prognosis in patients with myocardial infarction and without previously known Type 2 diabetes
Diabetic Medicine, 2008, 25(8), 949-955.
A comparison of diabetes clinics with different emphasis on routine care, complications assessment and shared careDiabetic Medicine, 2008, 25(8), 974-978.
Diabetes care in hospital-the impact of a dedicated inpatient care teamDiabetic Medicine, 2008, 25(2), 147-151. DOI: 10.1111/j.1464-5491.2007.02326.x
Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunctionDiabetic Medicine, 2008, 25(2), 138-146. DOI: 10.1111/j.1464-5491.2007.02338.x
Variable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutationDiabetic Medicine, 2008, 25(6), 651-656. DOI: 10.1111/j.1464-5491.2008.02443.x
Implementing a national quality assurance system for diabetes care: the Scottish Diabetes Survey 2001–2006Diabetic Medicine, 2008, 25(6), 743-746. DOI: 10.1111/j.1464-5491.2008.02453.x
Continuous Subcutaneous Glucose Monitoring System in diabetic mothers during labour and postnatal glucose adaptation of their infantsDiabetic Medicine, 2008, 25(4), 450-454. DOI: 10.1111/j.1464-5491.2008.02416.x
Subclinical right ventricular dysfunction in diabetes mellitus—an ultrasonic strain/strain rate studyDiabetic Medicine, 2007, 24(6), 656-663. DOI: 10.1111/j.1464-5491.2007.02101.x
Foot abnormalities in Canadian Aboriginal adolescents with Type 2 diabetesDiabetic Medicine, 2007, 24(7), 747-752. DOI: 10.1111/j.1464-5491.2007.02133.x
Glucose tolerance status and cognitive impairment in early middle-aged womenDiabetic Medicine, 2007, 24(7), 788-791. DOI: 10.1111/j.1464-5491.2007.02170.x
Prevalence of the diabetic foot syndrome at the primary care level in Germany: a cross-sectional studyDiabetic Medicine, 2008, 25(5), 557-563. DOI: 10.1111/j.1464-5491.2008.02435.x
Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetesDiabetic Medicine, 2008, 25(10), 1157-1163. DOI: 10.1111/j.1464-5491.2008.02572.x
Prevalence and determinants of diabetes mellitus in the Indian industrial populationDiabetic Medicine, 2008, 25(10), 1187-1194. DOI: 10.1111/j.1464-5491.2008.02554.x
Impact of diabetes and gender on survival after acute myocardial infarction in the Province of Quebec, Canada—a population-based studyDiabetic Medicine, 2009, 26(6), 609-616. DOI: 10.1111/j.1464-5491.2009.02740.x
Influence of glycaemic control on platelet bound CD40-CD40L system, P-selectin and soluble CD40 ligand in Type 2 diabetesDiabetic Medicine, 2010, 27(4), 384-390. DOI: 10.1111/j.1464-5491.2010.02957.x
Mortality of young patients with diabetes in Kinshasa, DR CongoDiabetic Medicine, 2010, 27(4), 405-411. DOI: 10.1111/j.1464-5491.2010.02961.x
Relationship between GLP-1 levels and dipeptidyl peptidase-4 activity in different glucose tolerance conditionsDiabetic Medicine, 2010, 27(6), 691-695. DOI: 10.1111/j.1464-5491.2010.03010.x
Severe statin-induced rhabdomyolysis mimicking Guillain-Barre syndrome in four patients with diabetes mellitus treated with fusidic acidDiabetic Medicine, 2010, 27(6), 696-700. DOI: 10.1111/j.1464-5491.2010.02984.x
The risk of overt diabetes mellitus among women with gestational diabetes: a population-based studyDiabetic Medicine, 2010, 27(7), 779-785. DOI: 10.1111/j.1464-5491.2010.02995.x
A clinical analysis of diabetic patients with hand ulcer in a diabetic foot centreDiabetic Medicine, 2010, 27(7), 848-851. DOI: 10.1111/j.1464-5491.2010.03012.x
Telephone follow-up to improve glycaemic control in patients with Type 2 diabetes: systematic review and meta-analysis of controlled trialsDiabetic Medicine, 2010, 27(11), 1217-1225. DOI: 10.1111/j.1464-5491.2010.03113.x
Diabetes management of elective hospital admissionsDiabetic Medicine, 2010, 27(11), 1289-1294. DOI: 10.1111/j.1464-5491.2010.03114.x
Predictors of incident major depression in diabetic outpatients with subthreshold depressionDiabetic Medicine, 2010, 27(11), 1295-1301. DOI: 10.1111/j.1464-5491.2010.03119.x
High prevalence of diabetes mellitus in patients with liver cirrhosisDiabetic Medicine, 2010, 27(11), 1308-1311. DOI: 10.1111/j.1464-5491.2010.03093.x
Patient safety systems in the primary health care of diabetes-a story of missed opportunities?Diabetic Medicine, 2010, 27(11), 1322-1326. DOI: 10.1111/j.1464-5491.2010.03106.x
A method of identifying and correcting miscoding, misclassification and misdiagnosis in diabetes: a pilot and validation study of routinely collected dataDiabetic Medicine, 2010, 27(2), 203-206. DOI: 10.1111/j.1464-5491.2009.02917.x
More co-morbid depression in patients with Type 2 diabetes with multiple complications. An observational study at a specialized outpatient clinicDiabetic Medicine, 2011, 28(1), 86-89. DOI: 10.1111/j.1464-5491.2010.03125.x
Efficacy and safety of pregabalin for treating neuropathic pain associated with diabetic peripheral neuropathy: a 14 week, randomized, double-blind, placebo-controlled trialDiabetic Medicine, 2011, 28(1), 109-116. DOI: 10.1111/j.1464-5491.2010.03152.x
An exercise programme for patients with diabetic complications: a study on feasibility and preliminary effectivenessDiabetic Medicine, 2011, 28(2), 212-217. DOI: 10.1111/j.1464-5491.2010.03128.x
Prevalence of injection-meal interval usage and its association with variables of metabolic control in patients with Type 1 and Type 2 diabetesDiabetic Medicine, 2011, 28(2), 223-226. DOI: 10.1111/j.1464-5491.2010.03172.x
Nurse-led interventions used to improve control of high blood pressure in people with diabetes: a systematic review and meta-analysisDiabetic Medicine, 2011, 28(3), 250-261. DOI: 10.1111/j.1464-5491.2010.03204.x
Cardiovascular autonomic neuropathy contributes to left ventricular diastolic dysfunction in subjects with Type 2 diabetes and impaired glucose tolerance undergoing coronary angiographyDiabetic Medicine, 2011, 28(3), 311-318. DOI: 10.1111/j.1464-5491.2010.03221.x
Association between vitamin D and diabetic neuropathy in a nationally representative sample: results from 2001−2004 NHANESDiabetic Medicine, 2012, 29(1), 50-55. DOI: 10.1111/j.1464-5491.2011.03379.x
An increase in HbA1c after percutaneous coronary intervention raises the risk for restenosis in patients without Type 2 diabetes mellitusDiabetic Medicine, 2008, 25(2), 228-231. DOI: 10.1111/j.1464-5491.2007.02320.x
Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitusDiabetic Medicine, 2008, 25(3), 333-340. DOI: 10.1111/j.1464-5491.2007.02375.x
Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)?Diabetic Medicine, 2008, 25(7), 788-791. DOI: 10.1111/j.1464-5491.2008.02467.x
Relationship between autonomic neuropathy and hypertension-are we underestimating the problem?Diabetic Medicine, 2008, 25(7), 863-866. DOI: 10.1111/j.1464-5491.2008.02458.x
Preventive behaviour in adult offspring of Type 2 diabetic patients and its relationship to parental adviceDiabetic Medicine, 2008, 25(11), 1343-1348. DOI: 10.1111/j.1464-5491.2008.02582.x
An association between Type 2 diabetes and α1-antitrypsin deficiencyDiabetic Medicine, 2008, 25(11), 1370-1373. DOI: 10.1111/j.1464-5491.2008.02584.x
Increasing incidence of abnormal glucose tolerance in women with prior abnormal glucose tolerance during pregnancy: DIAGEST 2 studyDiabetic Medicine, 2008, 25(1), 58-64. DOI: 10.1111/j.1464-5491.2007.02306.x
Symptoms of depression and diabetes-specific emotional distress are associated with a negative appraisal of insulin therapy in insulin-naive patients with Type 2 diabetes mellitus. A study from the European Depression in Diabetes [EDID] Research ConsortiumDiabetic Medicine, 2009, 26(1), 28-33. DOI: 10.1111/j.1464-5491.2008.02606.x
Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR)Diabetic Medicine, 2009, 26(1), 53-60. DOI: 10.1111/j.1464-5491.2008.02633.x
Ethnic variation in the correlation between random serum glucose concentration and glycated haemoglobinDiabetic Medicine, 2009, 26(2), 128-133. DOI: 10.1111/j.1464-5491.2008.02646.x
Prevalence of known diabetes in German adults aged 25-69 years: results from national health surveys over 15 yearsDiabetic Medicine, 2009, 26(6), 655-658. DOI: 10.1111/j.1464-5491.2009.02739.x
Validation of the International Classification of Functioning, Disability and Health (ICF) core set for diabetes mellitus from the patient perspective using focus groupsDiabetic Medicine, 2009, 26(7), 700-707. DOI: 10.1111/j.1464-5491.2009.02762.x
Stabilizing effect of exenatide in a patient with C-peptide-negative diabetes mellitusDiabetic Medicine, 2009, 26(9), 935-938. DOI: 10.1111/j.1464-5491.2009.02789.x
Magnitude of foot problems in diabetes in the developing world: a study of 1044 patientsDiabetic Medicine, 2009, 26(9), 939-942. DOI: 10.1111/j.1464-5491.2009.02781.x
Incorrect and incomplete coding and classification of diabetes: a systematic reviewDiabetic Medicine, 2010, 27(5), 491-497. DOI: 10.1111/j.1464-5491.2009.02920.x
Prevalence of pain and association with quality of life, depression and glycaemic control in patients with diabetesDiabetic Medicine, 2010, 27(5), 578-584. DOI: 10.1111/j.1464-5491.2010.02971.x
Comparison of the prognostic importance of diagnosed diabetes, co-morbidity and frailty in older peopleDiabetic Medicine, 2010, 27(5), 603-606. DOI: 10.1111/j.1464-5491.2010.02977.x
Cost variation in diabetes care delivered in English hospitalsDiabetic Medicine, 2010, 27(8), 949-957. DOI: 10.1111/j.1464-5491.2010.03031.x
The impact of sickle cell trait on glycated haemoglobin in diabetes mellitusDiabetic Medicine, 2010, 27(9), 1012-1016. DOI: 10.1111/j.1464-5491.2010.03050.x
Caring for older adults with diabetes mellitus: characteristics of carers and their prime roles and responsibilitiesDiabetic Medicine, 2010, 27(9), 1055-1059. DOI: 10.1111/j.1464-5491.2010.03066.x
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinoprilDiabetic Medicine, 2010, 27(10), 1144-1150. DOI: 10.1111/j.1464-5491.2010.03083.x
Validation of diabetes case definitions using administrative claims dataDiabetic Medicine, 2011, 28(4), 424-427. DOI: 10.1111/j.1464-5491.2011.03238.x
Pan-insulin allergy and severe lipoatrophy complicating Type 2 diabetesDiabetic Medicine, 2011, 28(4), 500-503. DOI: 10.1111/j.1464-5491.2010.03196.x
Alterations of tendons in patients with diabetes mellitus: a systematic reviewDiabetic Medicine, 2011, 28(8), 886-895. DOI: 10.1111/j.1464-5491.2010.03197.x
Diabetes prevalence based on health insurance claims: large differences between companiesDiabetic Medicine, 2011, 28(8), 919-923. DOI: 10.1111/j.1464-5491.2011.03305.x
Presentation and clinical course of Wolfram (DIDMOAD) syndrome from North IndiaDiabetic Medicine, 2011, 28(11), 1337-1342. DOI: 10.1111/j.1464-5491.2011.03377.x
Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International StudyDiabetic Medicine, 2011, 28(11), 1343-1351. DOI: 10.1111/j.1464-5491.2011.03360.x
Association of a polymorphism of BTN2A1 with Type 2 diabetes mellitus in Japanese individualsDiabetic Medicine, 2011, 28(11), 1381-1387. DOI: 10.1111/j.1464-5491.2011.03358.x
Neuropad: evaluation of three cut-off points of sudomotor dysfunction for early detection of polyneuropathy in recently diagnosed diabetesDiabetic Medicine, 2011, 28(11), 1412-1415. DOI: 10.1111/j.1464-5491.2011.03345.x
Improvement of diabetes care in a small but geographically widely spread population in Greenland. Effects of a national diabetes care programmeDiabetic Medicine, 2011, 28(11), 1425-1432. DOI: 10.1111/j.1464-5491.2011.03337.x
Time trends in absolute and modifiable coronary heart disease risk in patients with Type 2 diabetes in the Swedish National Diabetes Register (NDR) 2003-2008Diabetic Medicine, 2012, 29(2), 198-206. DOI: 10.1111/j.1464-5491.2011.03425.x
Oral contraception enhances growth hormone responsiveness to hyper- and hypoglycaemiaDiabetic Medicine, 2012, 29(3), 345-350. DOI: 10.1111/j.1464-5491.2011.03430.x
Automated identification of miscoded and misclassified cases of diabetes from computer recordsDiabetic Medicine, 2012, 29(3), 410-414. DOI: 10.1111/j.1464-5491.2011.03457.x
The rs553668 polymorphism of the ADRA2A gene predicts the worsening of fasting glucose values in a cohort of subjects without diabetes. A population-based studyDiabetic Medicine, 2012, 29(4), 549-552. DOI: 10.1111/j.1464-5491.2011.03522.x
Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes-the CORALL studyDiabetic Medicine, 2012, 29(5), 628-631. DOI: 10.1111/j.1464-5491.2011.03553.x
Ethnicity modifies the relation between fasting plasma glucose and HbA1c in Indians, Malays and ChineseDiabetic Medicine, 2012, 29(7), 911-917. DOI: 10.1111/j.1464-5491.2012.03599.x
Comparison of renal resistive index among patients with Type 2 diabetes with different levels of creatinine clearance and urinary albumin excretionDiabetic Medicine, 2012, 29(8), 1043-1046. DOI: 10.1111/j.1464-5491.2012.03593.x
A diabetes scorecard does not improve HbA1c, blood pressure, lipids, aspirin usage, exercise and diabetes knowledge over 9 months: a randomized controlled trialDiabetic Medicine, 2012, 29(9), 1206-1212. DOI: 10.1111/j.1464-5491.2012.03610.x
Predictors of large and small for gestational age birthweight in offspring of women with gestational diabetes mellitusDiabetic Medicine, 2013, 30(9), 1040-1046. DOI: 10.1111/dme.12207
Risk factors for diabetic retinopathy in a South Indian Type 2 diabetic population—the Chennai Urban Rural Epidemiology Study (CURES) Eye Study 4Diabetic Medicine, 2008, 25(5), 536-542. DOI: 10.1111/j.1464-5491.2008.02423.x
Health utility values associated with diabetic retinopathyDiabetic Medicine, 2008, 25(5), 618-624. DOI: 10.1111/j.1464-5491.2008.02430.x
The Y402H variant of complement factor H is associated with age-related macular degeneration but not with diabetic retinal disease in the Go-DARTS studyDiabetic Medicine, 2009, 26(5), 460-465. DOI: 10.1111/j.1464-5491.2009.02719.x
Long-term impact of retinal screening on significant diabetes-related visual impairment in the working age populationDiabetic Medicine, 2009, 26(5), 489-492. DOI: 10.1111/j.1464-5491.2009.02718.x
Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programmeDiabetic Medicine, 2009, 26(10), 1040-1047. DOI: 10.1111/j.1464-5491.2009.02820.x
Pregnancy-induced sight-threatening diabetic retinopathy in women with Type 1 diabetesDiabetic Medicine, 2010, 27(4), 431-435.
Is risk of diabetic retinopathy lower in Australia’s Greek-born migrants?Diabetic Medicine, 2010, 27(6), 660-665. DOI: 10.1111/j.1464-5491.2010.03005.x
Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT ProgrammeDiabetic Medicine, 2011, 28(3), 345-351. DOI: 10.1111/j.1464-5491.2010.03210.x
Increased levels of monokine induced by interferon-γ (Mig) in the vitreous of patients with diabetic retinopathyDiabetic Medicine, 2008, 25(7), 875-877. DOI: 10.1111/j.1464-5491.2008.02466.x
Reliability of screening methods for diabetic retinopathyDiabetic Medicine, 2009, 26(8), 783-790. DOI: 10.1111/j.1464-5491.2009.02778.x
Blood pressure control and awareness among patients with diabetes and hypertension attending a tertiary ophthalmic clinicDiabetic Medicine, 2009, 26(1), 34-39. DOI: 10.1111/j.1464-5491.2008.02614.x
Diabetic retinopathy screening: a systematic review of the economic evidenceDiabetic Medicine, 2010, 27(3), 249-256. DOI: 10.1111/j.1464-5491.2009.02870.x
Socio-economic and ethnic inequalities in diabetes retinal screeningDiabetic Medicine, 2010, 27(3), 282-288. DOI: 10.1111/j.1464-5491.2010.02946.x
Association between alcohol consumption and diabetic retinopathy and visual acuity-the AdRem StudyDiabetic Medicine, 2010, 27(10), 1130-1137. DOI: 10.1111/j.1464-5491.2010.03080.x
Do type 2 diabetes patients without diabetic retinopathy or subjects with impaired fasting glucose have impaired colour vision? The Okubo Color Study ReportDiabetic Medicine, 2011, 28(7), 865-871. DOI: 10.1111/j.1464-5491.2011.03290.x
External quality assurance for image grading in the Scottish Diabetic Retinopathy Screening ProgrammeDiabetic Medicine, 2012, 29(6), 776-783. DOI: 10.1111/j.1464-5491.2011.03504.x
Preferences of people with diabetes for diabetic retinopathy screening: a discrete choice experimentDiabetic Medicine, 2012, 29(7), 869-877. DOI: 10.1111/j.1464-5491.2012.03636.x
Diabetic retinopathy screening: perspectives of people with diabetes, screening intervals and costs of attending screeningDiabetic Medicine, 2012, 29(7), 878-885. DOI: 10.1111/j.1464-5491.2012.03637.x
Prevalence of diabetic retinopathy in Type 2 diabetes in developing and developed countriesDiabetic Medicine, 2013, 30(4), 387-398. DOI: 10.1111/dme.12119
Long-term impact of retinal screening on significant diabetes-related visual impairment in the working age populationDiabetic Medicine, 2009, 26(5), 489-492. DOI: 10.1111/j.1464-5491.2009.02718.x
Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programmeDiabetic Medicine, 2009, 26(10), 1040-1047. DOI: 10.1111/j.1464-5491.2009.02820.x
Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic reviewDiabetic Medicine, 2013, 30(4), 399-412. DOI: 10.1111/j.1464-5491.2012.03756.x
Macular oedema is not predicted by perifoveal single blot haemorrhagesDiabetic Medicine, 2008, 25(2), 129-133. DOI: 10.1111/j.1464-5491.2007.02330.x
Notification of random hyperglycaemia to general practitioners by an emergency medicine team: impact of a simple intervention planDiabetic Medicine, 2008, 25(6), 751-754. DOI: 10.1111/j.1464-5491.2008.02447.x
Socioeconomic factors related to attendance at a Type 2 diabetes screening programmeDiabetic Medicine, 2009, 26(5), 518-525. DOI: 10.1111/j.1464-5491.2009.02715.x
Trends in yield and effects of screening intervals during 17 years of a large UK community-based diabetic retinopathy screening programmeDiabetic Medicine, 2009, 26(10), 1040-1047. DOI: 10.1111/j.1464-5491.2009.02820.x
Performance of HbA1c for detecting newly diagnosed diabetes and pre-diabetes in Chinese communities living in BeijingDiabetic Medicine, 2009, 26(12), 1262-1268. DOI: 10.1111/j.1464-5491.2009.02831.x
A national survey of the current state of screening services for diabetic retinopathy: ABCD–Diabetes UK survey of specialist diabetes services 2006Diabetic Medicine, 2009, 26(12), 1301-1305. DOI: 10.1111/j.1464-5491.2009.02838.x
Performance of existing risk scores in screening for undiagnosed diabetes: an external validation studyDiabetic Medicine, 2010, 27(1), 46-53. DOI: 10.1111/j.1464-5491.2009.02891.x
A simple risk score to identify Southern Chinese at high risk for diabetesDiabetic Medicine, 2010, 27(6), 644-649. DOI: 10.1111/j.1464-5491.2010.02993.x
The importance of postpartum glucose tolerance testing after pregnancies complicated by gestational diabetesDiabetic Medicine, 2010, 27(6), 650-654. DOI: 10.1111/j.1464-5491.2010.03001.x
The Finnish Diabetes Risk Score is associated with insulin resistance but not reduced β-cell function, by classical and model-based estimatesDiabetic Medicine, 2011, 28(9), 1078-1081. DOI: 10.1111/j.1464-5491.2011.03315.x
Undiagnosed diabetes in the over-60s: performance of the Association of Public Health Observatories (APHO) Diabetes Prevalence Model in a general practiceDiabetic Medicine, 2012, 29(1), 115-120. DOI: 10.1111/j.1464-5491.2011.03389.x
Undiagnosed diabetes-data from the English longitudinal study of ageingDiabetic Medicine, 2009, 26(7), 679-685. DOI: 10.1111/j.1464-5491.2009.02755.x
Gestational diabetes: fasting capillary glucose as a screening test in a multi-ethnic, high-risk populationDiabetic Medicine, 2009, 26(8), 760-765. DOI: 10.1111/j.1464-5491.2009.02765.x
Reliability of screening methods for diabetic retinopathyDiabetic Medicine, 2009, 26(8), 783-790. DOI: 10.1111/j.1464-5491.2009.02778.x
Validation of an algorithm combining haemoglobin A1c and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populationsDiabetic Medicine, 2009, 26(2), 115-121. DOI: 10.1111/j.1464-5491.2008.02652.x
How much might cardiovascular disease risk be reduced by intensive therapy in people with screen-detected diabetes?Diabetic Medicine, 2008, 25(12), 1433-1439. DOI: 10.1111/j.1464-5491.2008.02600.x
Socio-economic and ethnic inequalities in diabetes retinal screeningDiabetic Medicine, 2010, 27(3), 282-288. DOI: 10.1111/j.1464-5491.2010.02946.x
The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK settingDiabetic Medicine, 2010, 27(8), 887-895. DOI: 10.1111/j.1464-5491.2010.03037.x
The prevalence of depressive symptoms in a white European and South Asian population with impaired glucose regulation and screen-detected Type 2 diabetes mellitus: a comparison of two screening toolsDiabetic Medicine, 2010, 27(8), 896-905. DOI: 10.1111/j.1464-5491.2010.03042.x
Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge studyDiabetic Medicine, 2010, 27(9), 995-1003. DOI: 10.1111/j.1464-5491.2010.03056.x
Measuring the accuracy of different ways to identify the ‘at-risk’ foot in routine clinical practiceDiabetic Medicine, 2011, 28(6), 747-754. DOI: 10.1111/j.1464-5491.2011.03297.x
The association between anxiety and measures of glycaemia in a population-based diabetes screening programmeDiabetic Medicine, 2011, 28(7), 785-788. DOI: 10.1111/j.1464-5491.2011.03245.x
Screening for Type 2 diabetes. Lessons from the ADDITION-Europe studyDiabetic Medicine, 2011, 28(11), 1416-1424. DOI: 10.1111/j.1464-5491.2011.03365.x
Establishing an evidence base for frequency of monitoring glycated haemoglobin levels in patients with Type 2 diabetes: projections of effectiveness from a regression modelDiabetic Medicine, 2012, 29(2), 266-271. DOI: 10.1111/j.1464-5491.2011.03412.x
Validity of self-assessed waist circumference in a multi-ethnic UK populationDiabetic Medicine, 2012, 29(3), 404-409. DOI: 10.1111/j.1464-5491.2011.03478.x
A simple strategy for screening for glucose intolerance, using glycated haemoglobin, in individuals admitted with acute coronary syndromeDiabetic Medicine, 2012, 29(7), 838-843. DOI: 10.1111/j.1464-5491.2012.03643.x
Effect of screening for Type 2 diabetes on population-level self-rated health outcomes and measures of cardiovascular risk: 13-year follow-up of the Ely cohortDiabetic Medicine, 2012, 29(7), 886-892. DOI: 10.1111/j.1464-5491.2012.03570.x
The cost of diagnosing Type 2 diabetes mellitus by clinical opportunistic screening in general practiceDiabetic Medicine, 2012, 29(7), 863-868. DOI: 10.1111/j.1464-5491.2012.03607.x
Estimating the potential population impact of stepwise screening strategies for identifying and treating individuals at high risk of Type 2 diabetes: a modelling studyDiabetic Medicine, 2012, 29(7), 893-904. DOI: 10.1111/j.1464-5491.2012.03609.x
Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A reviewDiabetic Medicine, 2012, 29(7), 844-854. DOI: 10.1111/j.1464-5491.2011.03541.x
Blood glucose testing and primary prevention of Type 2 diabetes-evaluation of the effect of evidence-based patient information: a randomized controlled trialDiabetic Medicine, 2012, 29(8), 1011-1020. DOI: 10.1111/j.1464-5491.2011.03531.x
Screening for diabetic retinopathy in pregnancy using photographic review clinicsDiabetic Medicine, 2013, 30(4), 475-477. DOI: 10.1111/dme.12077